Twitter Beğeni Hilesi

How to treat Thyroid cancers in 2024 . Data of FDA approved and Non FDA approved TKI in Thyroid cancer and frequency of mutations in each subtype . Taken from review published in JCO Oncology Practice ASCO

Similar to DESTINY-CRC01, most responses were seen in HER2 IHC 3+ tumors. HER2 expression does matter, for T-DXd efficacy.

Had a great time talking about treatment options in the second line for HER2+ metastatic breast cancer, thanks to VuMedi for inviting me! vumedi.com/video/treatmen…

Check our recent paper UAMS Myeloma Center AmericanJournalofHematology #mmsm : Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma ➡️ onlinelibrary.wiley.com/doi/10.1002/aj… ✅n=1379 ✅Median FU:16.6 yrs ✅SHM:5.6% (1 vs 2 transplants=no difference)

👩🏽‍🏫 my ASCO TECAG colleagues and I put together this workbook on the what, when, why, and how of mentoring for #hemeonc trainees and early career physicians Check it out 👀 and let us know how you’ve been able to form effective mentoring relationships! ASCO Hem-Onc Fellows Network

Thanks to ASCO for showcasing our insights on ASCO Daily News about the current and future impact of AI on clinical oncology practice. Exciting to collaborate with my mentor and boss Doug Flora MD, LSSBB on this important topic! #Oncology #AI #ClinicalPractice dailynews.ascopubs.org/do/future-onco…

#Melanoma: This is the #algorithm we have used during our discussion w/ Allison Betof Warner, MD, PhD to cover the current landscape/SoC in cutaneous melanoma. #OncTwitter CancerNetwork® #MedTwitter #OncEd

The experience of breast cancer can be psychologically traumatic long beyond initial diagnosis. In this piece, led by Cristiane D Bergerot, we review the emotional complexities faced by survivors & the psychological interventions designed to promote resilience. apm.amegroups.org/article/view/1…

✍️Mark your calendar for our next upcoming space‼️ Fellowship Application; The Program Director Perspective, with Dr. Rami Manochakian, Heme/onc Fellowship PD at Mayo Clinic FL❗️ 📅 Wednesday, 21st August 2024 ⏰ 7 pm EST Moderator: Noha N. Soror, MD, MSc. 𓂀 🌟Speaker: Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation

This is the algorithm we have used during our discussion on #DLBCL w/ Carla Casulo, MD. #lymphoma #lymsm #HemeTwitter #MedTwitter #OncEd CancerNetwork®

We have a fun and exciting agenda! Join us in San Diego to be prepared for your grant application!

Purposeful mentorship & sponsorship opportunities are still limited for women in #hemeonc Esp mentors who can help shape career,give authorship opportunities, develop leadership skills etc. The scarcity is more pronounced for women of color. Women In Medicine® Hematology & Oncology Women Physicians Group—HOWPG

#MARIPOSA: Ph III, n= 1074, 1L Ami + lazertinib in EGFR mNSCLC - Ami + Laz now FDA Oncology approved in 1L - Improved PFS in ALL high risk features (HR: 0.49 to 0.71) from recent #ASCO24 #lcsm #onctwitter #MedTwitter

Lift up & celebrate your #WomeninOncology colleagues and friends! Submit your nominations for the #LEAD2024 Woman Oncologist of the Year Award & Rising Star Award by August 30th 🔗bioascend.com/lead-awards/ Women Leaders in Oncology Hematology & Oncology Women Physicians Group—HOWPG Hem-Onc Fellows Network ASCO TECAG Women In Lymphoma - [email protected]

Join us tomorrow for an exceptional twitter space with the amazing Dr. Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation , Chair ASCO Training Programs Committee and PD @Mayoclinicflorida Hematology-Oncology Fellowship‼️ H.O.M.E ASCO TECAG IMG Oncologists

Hopefully these algorithms for the treatment of #breastcancer make your life a little easier. National Comprehensive Cancer Network (NCCN) were a bit confusing for me. These incorporate several resources for your non-breast onc docs. #bcsm #MedTwitter #OncTwitter Check out Ilana Schlam algorithms and @asco guidelines

#Hematology: w/ Jorge Cortes MD we 🗣️ the current SoC/landscape for #CML (1st, 2nd, and 3rd Gen TKIs) Full discussion: ⭐️ cancernetwork.com/treatment-algo… ⭐️ oncbrothers.com/cml-2024 ⭐️ Also on the “Oncology Brothers” podcast #HemeTwitter #MedTwitter #OncTwitter CancerNetwork® #leusm

Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor–Positive Breast Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert

We invite you to complete a brief survey to help us identify your needs and priorities for Binaytara Foundation's upcoming Summit on Cancer Health Disparities. Your insights will be used to design a program that addresses critical issues, provides practical solutions, and fosters